All Curated Mutation Sites in HPV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All

E1^E4

Keyword: Uterine Cervical Diseases-35552511

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	35552511	A424T	L2	L2	Uterine Cervical Diseases	G R S L	View
2	35552511	A443G	L2	L2	Uterine Cervical Diseases	G R S L	View
3	35552511	D272N	L2	L2	Uterine Cervical Diseases	G R S L	View
4	35552511	D334H	L2	L2	Uterine Cervical Diseases	G R S L	View
5	35552511	D334N	L2	L2	Uterine Cervical Diseases	G R S L	View
6	35552511	D334T	L2	L2	Uterine Cervical Diseases	G R S L	View
7	35552511	E338D	L2	L2	Uterine Cervical Diseases	G R S L	View
8	35552511	H354Q	L2	L2	Uterine Cervical Diseases	G R S L	View
9	35552511	I306L	L2	L2	Uterine Cervical Diseases	G R S L	View
10	35552511	I418M	L2	L2	Uterine Cervical Diseases	G R S L	View
11	35552511	I420T	L2	L2	Uterine Cervical Diseases	G R S L	View
12	35552511	I428L	L2	L2	Uterine Cervical Diseases	G R S L	View
13	35552511	L266F	L2	L2	Uterine Cervical Diseases	G R S L	View
14	35552511	L330F	L2	L2	Uterine Cervical Diseases	G R S L	View
15	35552511	L390F	L2	L2	Uterine Cervical Diseases	G R S L	View
16	35552511	L75F	L2	L2	Uterine Cervical Diseases	G R S L	View
17	35552511	N273S	L2	L2	Uterine Cervical Diseases	G R S L	View
18	35552511	Q342L	L2	L2	Uterine Cervical Diseases	G R S L	View
19	35552511	Q423H	L2	L2	Uterine Cervical Diseases	G R S L	View
20	35552511	S122A	L2	L2	Uterine Cervical Diseases	G R S I L	View
21	35552511	S122P	L2	L2	Uterine Cervical Diseases	G R S I L	View
22	35552511	S134R	L2	L2	Uterine Cervical Diseases	G R S L	View
23	35552511	S269P	L2	L2	Uterine Cervical Diseases	G R S L	View
24	35552511	S270N	L2	L2	Uterine Cervical Diseases	G R S L	View
25	35552511	S378F	L2	L2	Uterine Cervical Diseases	G R S L	View
26	35552511	S378V	L2	L2	Uterine Cervical Diseases	G R S L	View
27	35552511	S384A	L2	L2	Uterine Cervical Diseases	G R S L	View
28	35552511	S426A	L2	L2	Uterine Cervical Diseases	G R S L	View
29	35552511	T245A	L2	L2	Uterine Cervical Diseases	G R S I L	View
30	35552511	T332S	L2	L2	Uterine Cervical Diseases	G R S L	View
31	35552511	T352P	L2	L2	Uterine Cervical Diseases	G R S L	View
32	35552511	T377S	L2	L2	Uterine Cervical Diseases	G R S L	View
33	35552511	T85A	L2	L2	Uterine Cervical Diseases	G R S I L	View
34	35552511	T94A	L2	L2	Uterine Cervical Diseases	G R S L	View
35	35552511	V385I	L2	L2	Uterine Cervical Diseases	G R S L	View

Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.